Skip to content

Aphea.Bio

Active Public limited companyfounded 2016active for 9 yearsTechnologiepark-Zwijnaarde 21, 9052 GhentKBO/BCE: BE 0666.961.607 #8 company by staff growth in East Flanders, Research and development sector

Lifetime

9 annual accounts with figures on one time axis
peak of €2.0m in 2023
-not published
lowest -€14.5m in 2024
-€14.1m▲ €454,083
peak of €25.5m in 2024
€11.4m▼ 55.2%
€4.8m▼ 0.5%
peak of 56.9 FTE in 2025
56.9 FTE▲ 0.5%
Board11 names since 2016
6 directors and 5 others
Owners7 names in the annual accountsall names
4.86% and 1 other
Documentsfilings and deeds
21-08-202621 days late
2025financial year
Turnover from €23,000 to €14,118Loss of €14.1m4 directors appointed, 3 resignations 29-12Equity from €25.5m to €11.4mCash from €949,303 to €580,919

Key points

from the 2025 annual accounts

Equity

€11.4m from €25.5m in 2024

Equity fell by 55% in 1 year.

Losses

-€64.1m in nine years
2017201820192020202120222023-14.52024-14.12025

Every financial year from 2017 to 2025 closed with a loss. 2024 was the heaviest.

Payment terms

63 days to suppliers
Suppliers
49 to 63
Customers
4637 to 2738

Aphea.Bio pays its suppliers 14 days later than in 2024. Customers pay 1,899 days earlier.

Board

10 joined · 5 left

10 directors joined and 5 left, the latest change on 15-09-2026. 10 are in office now.

Position in the sector

-€14.1m

Lower net result than 95% of companies in research and development. The sector median is €66,615, over 121 companies.

Public support

€4.9m awarded from 2022 to 2025
2022202320242025

Aphea.Bio was awarded €4.9m in Flemish support from 2022 to 2025, mostly under Ontwikkelingsproject.

2025 accounts filed 21 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 150 companies had the same profile as Aphea.Bio has now. Each dot is one company, two years later.

92.0%
were still trading
5.3%
stopped another way
2.0%
went bankrupt
  • Medium-sized
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
  • without age

Another 0.7% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 150 companies, not a prediction for Aphea.Bio. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 30-09-2021
Director, since 20-07-2023
Director, , since 20-07-2023
Director, since 27-11-2025
Director, since 27-11-2025
Auditor,
and 5 others
  • 10.89%score equity €75.3m (2025) · annual accounts 2025 of
  • 4.86%score equity €52.6m (2025) · annual accounts 2025 of
  • 1.76%score equity €7.7m (2025) · annual accounts 2025 of
and 2 other shareholdersBoard & ownership

Recent changes

appointed as director General meeting of 15-09-2026 · Gazette deed
reappointed as statutory auditor General meeting of 15-07-2026 · Gazette deed
6 directors appointed, 7 resignations The capital rose from €51,955,310.15 to €76,055,310.74 · The capital fell from €76,055,310.74 to €35,546,749.74 · ., , , , , and 1 other resign · General meeting of 06-07-2026 · Gazette deed
resigns as director General meeting of 29-01-2026 · Gazette deed
All 39 events

Comparable companies

same main activity, similar in size and age
Company
Aphea.Bio Ghent €14,118 - 70.5% 56.9
Confo Therapeutics Ghent €176,727 - 88.1% 59
Biotalys Ghent - - 60.6% 58.2
EPICS THERAPEUTICS Charleroi - - 62.0% 32.2
Ziphius Ghent - - 62.1% 41.2
Microbial Resource Management Health Ghent - - 59.2% 22.8
ProDigest Ghent - - 65.9% 39.8

These companies have the same main activity as Aphea.Bio: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €7.8m and €38m, founded between 2008 and 2020.

Official details

Source: KBO
Status
Active since 05-12-2016Normal situation
Activity
Research and development on biotechnologyNACE 72101and 1 other
Joint committee
207White-collar workers in the chemical industry · annual accounts 2025
Establishment unit
2.259.481.9709052 Ghent, registered on 05-12-2016
Financial year end
31 December
Peppol
Reachable since 20-11-2020
Company details

Annual accounts 2025

€14.3m▲ 6.7%
€16.2m▼ 46.5%
Employeeson 31-12-2025
51▼ 15.0%
Filing
Filed on 21-08-2026
Financials

Companies linked to Aphea.Bio

Shareholders

Insights on Aphea.Bio

Solvency fell in 2025 from 84.1% to 70.5% because of the loss.

In July 2023, five directors stepped down.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Aphea.Bio

What is the company number of Aphea.Bio?
The company number of Aphea.Bio is 0666.961.607. The VAT number is the same number with BE in front: BE 0666.961.607.
Where is Aphea.Bio based?
The registered office is at Technologiepark-Zwijnaarde 21, 9052 Ghent.Company details
What does Aphea.Bio do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Aphea.Bio?
Aphea.Bio is a public limited company (NV).
When was Aphea.Bio founded?
Aphea.Bio was founded on 05-12-2016.
Is Aphea.Bio still active?
Yes, Aphea.Bio is an active enterprise in the KBO register.
How many employees does Aphea.Bio have?
Aphea.Bio had an average of 56.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Aphea.Bio fall under?
In its 2025 annual accounts, Aphea.Bio states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of Aphea.Bio?
The turnover of Aphea.Bio was €14,118 in financial year 2025, according to the filed annual accounts.
Is Aphea.Bio profitable?
In financial year 2025, Aphea.Bio made a loss of €14.1m.
Where can I find the annual accounts of Aphea.Bio?
Aphea.Bio filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Aphea.Bio due?
Aphea.Bio must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.